Compare Abeona Therapeutics Inc (ABEO) vs Ginkgo Bioworks Holdings Inc (DNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Abeona Therapeutics Inc vs Ginkgo Bioworks Holdings Inc — how do they compare? Abeona Therapeutics Inc trades at $7.49 (market cap $421.19M), while Ginkgo Bioworks Holdings Inc trades at $7.36 (market cap $505.73M). The key difference: Ginkgo Bioworks Holdings Inc is the larger of the two by market cap, and Abeona Therapeutics Inc is trading nearer its 52-week high, Ginkgo Bioworks Holdings Inc nearer its low. Which is the better fit depends on your goals.
| ABEO | DNA | |
|---|---|---|
Market Cap | $421.19M | $505.73M |
Sector | Health | Health |
52-Week High | $7.45 | $16.14 |
52-Week Low | $4.17 | $5.48 |
Enterprise Value | $276.10M | $607.68M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →
